CLS-Logo-1.jpg
CLS Obtains EU Approval for New Thermometry Software Product, ThermoGuide, also Obtains Approval for Updated EC Certificate for Complete TRANBERG System including the Software
03. April 2020 11:00 ET | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, April 03, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it has obtained EU approval for its new thermometry software product, ThermoGuide, and...
CLS-Logo-1.jpg
CLS Presents Image-Guided Laser Thermotherapy Enhancements at MedTech Investing Europe Conference in London, UK
25. November 2019 03:00 ET | Clinical Laserthermia Systems Americas, Inc.
LONDON, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) will present its high precision, image-guided TRANBERG® çLaser Thermal Therapy System, new MRI-integrated...
CLS-Logo-1.jpg
Clinical Laserthermia Systems Americas Names Michael Magnani as Managing Director
17. Oktober 2019 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS Americas), a subsidiary of CLS AB in Lund, Sweden, today announced that industry veteran Michael...
CLS-Logo-1.jpg
Clinical Laserthermia Systems Americas Names Michael Magnani as Managing Director
17. Oktober 2019 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS Americas), a subsidiary of CLS AB in Lund, Sweden, today announced that industry veteran Michael...
CLS-Logo-1.jpg
Desert Medical Imaging Doctors Presented Interim Clinical Study Results of MR-guided FLA Treatment of MR-visible Prostate Cancer at AdMeTech 4th Global Summit
08. Oktober 2019 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) today announced that Bernadette M. Greenwood, BSc, PG Cert., RT(R)(MR) and John F. Feller, M.D. of Desert...
CLS-Logo-1.jpg
Toronto General Hospital Physicians Presented Interim Clinical Study Results for MR-guided FLA Treatment of Low-intermediate Risk Localized Prostate Cancer at AdMeTech 4th Global Summit
07. Oktober 2019 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (CLS) today announced that Dr. Sangeet Ghai and other physicians at Toronto General Hospital presented a poster at...
CLS-Logo-1.jpg
Toronto General Hospital Physicians Presented Interim Clinical Study Results for MR-guided FLA Treatment of Low-intermediate Risk Localized Prostate Cancer at AdMeTech 4th Global Summit
07. Oktober 2019 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
BOSTON, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (CLS) today announced that Dr. Sangeet Ghai and other physicians at Toronto General Hospital presented a poster at the...
CLS-Logo-1.jpg
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors ST. LOUIS and IRVINE, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. and Clinical Laserthermia Systems, AB (STO:CLS B) (CLS) today announced they have entered into a research...
CLS-Logo-1.jpg
CLS Presents Image-Guided Laser Immunotherapy System at 16th Annual Anglonordic Life Science Investor Conference
07. Mai 2019 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
CEO Will Discuss New Products, Clinical Studies, and Industry Partners LONDON, May 07, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) will present its TRANBERG® çThermal...
CLS-Logo-1.jpg
CLS Releases White Paper Regarding its imILT® Immuno-Stimulating Method for Treating Cancer Tumours at ECIO 2019 Conference
08. April 2019 03:45 ET | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, April 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today released a technical white paper regarding the company’s imILT® immuno-stimulating method for...